3 citations
,
January 2015 in “Journal of clinical and diagnostic research” This case report described a seven-year-old with tinea capitis, which improved clinically after six weeks of griseofulvin treatment, changing the fungal strain from Trichophyton violaceum white variant to violet strain.
1 citations
,
June 2022 in “International Journal of Infectious Diseases” This case report identifies a 13-year-old boy with disseminated tinea incognito, emphasizing the importance of considering fungal infections when red and scaly lesions persist despite corticosteroid treatment.
July 2024 in “Journal Archives of Health” This study reviewed existing literature on Tinea Capitis, highlighting its frequent occurrence in children, the ease of fungal spread from humans or animals, and the necessity for prompt and proper antifungal treatment due to potential drug resistance and complications like alopecia.
September 2023 in “Journal of the American Academy of Dermatology” This retrospective study found that among 20 pediatric patients in Rochester, MN, tinea capitis due to Trichophyton violaceum/soudanense presented with diverse scalp and body symptoms and suggested terbinafine may be more effective than griseofulvin for treatment.
August 2023 in “Authorea (Authorea)” This article highlights that tinea capitis, a fungal scalp infection primarily seen in children, is often misdiagnosed in adults, especially postmenopausal women and immunocompromised individuals, leading to unnecessary treatments and potential permanent hair loss if not correctly identified and treated.